 |
Andrea K. Brunson, Pfizer, USA
Andrea K. Brunson began her Pfizer career in September, 2003, as
logistics engineer in Pfizer’s US Market Logistics group in Memphis,
TN. She is currently Senior Manager of the Planning team with
America’s Market logistics group. Andrea earned a Bachelor of
Science in Mechanical Engineering degree in 1999 from The University
of Wisconsin. Prior to joining Pfizer, Andrea worked for a leading
consulting firm specializing in Retail Distribution. She currently
lives in Collierville, Tennessee |
 |
Geoff Power, Packaging Security
Specialist, Former Director of Packaging Security, GlaxoSmithKline,
UK
Geoff has some 35 years’ experience in Packaging Technology,
including 22 years with GlaxoSmithKline. Geoff recently retired as
Director of Packaging Security for GSK where he provided a packaging
support service to the GSK group world-wide. His responsibilities
included maintaining the security and integrity of healthcare
packaging operations, and developing a corporate protective strategy
against counterfeiting and adulteration. He set up a centralised
forensic examination service for suspect packs, and was responsible
for developing anti-counterfeit measures. Geoff was Technical
Advisor to the Pharmaceutical Security Institute, and authored a
technology briefing paper for WHO IMPACT.
|
 |
Andrew John Charvill, Analytical Assessor,
Medicines Testing Scheme, MHRA, UK
Andy Charvill is a chemist by training and has worked at the
Medicines and Healthcare products Regulatory Agency (MHRA, the UK
Competent Authority) as the Analytical Assessor for the Medicines
Testing Scheme (MTS), since 1994. Prior to this Andy was employed in
a variety of Quality Control/Quality Assurance positions in the
Pharmaceutical Industry, principally in the manufacture of Large
Volume Parenterals.
|
 |
Roberto Rosito, Essex Animal Health Friesoythe,
Germany
Roberto Rosito has more than 20 years experience in pharmaceutical
production. He worked at Hoechst’s subsidiary pharmaceutical plant
in Guatemala City and for Twardy’s packaging plant near Cologne.
Since 2003 he has been working as Project Manager at Essex Animal
Health Friesoythe a Division of Essex Pharma GmbH, responsible for
installation and operational qualification projects, conceptual
design of equipments and process optimization. |
 |
Dr Domenico Di Giorgio, Senior Chemist Officer, Anti-counterfeiting
Activities Manager Agenzia Italiana del Farmaco, Roma, Italy
Dr. Di Giorgio is coordinator and member of the organizing committee
of the AIFA-WHO international conference “Combating Counterfeit
Drugs” (Rome, 2006); Italian member of IMPACT, and Chairman of the
EDQM/CoE “Committee of experts on minimising public health risks
posed by counterfeiting of medical products and related crimes”.
|
 |
Michael S. Russo, Eli Lilly & Company, USA
Michael S. Russo joined Lilly in 1997. He is a global security
manager for Eli Lilly and Company based in Indianapolis, Indiana
USA. He is responsible for the management of Lilly’s Global Product
Protection Security Team which includes eight (8) experienced
investigators based in Asia, Europe and the US who handle cases
involving counterfeit, stolen and diverted pharmaceuticals. His
responsibilities also extend to general security support for Lilly
affiliates outside the United States. |
 |
Michaela Hähn, GS1 Germany GmbH, Cologne,
Germany
Michaela Hähn joined GS1 Germany, the German EAN organisation, in
1998. She is currently Senior Project Manager AIDC (Automatic
Identification and Data Capture).Responsible for the development of
new AIDC standards, Michaela is engaged in work on
anti-counterfeiting concepts, as well as GS1 Healthcare, the global
initiative of GS1 and the healthcare industry to improve patient
safety.
|
 |
Dr. Stephan Schwarze, Bayer Schering Pharma AG,
Berlin, Germany
Stephan Schwarze started his career at Schering AG Berlin in 1992
and is now heading the function Counterfeit Protection Management
since 2005. First within Schering AG Berlin and nowadays within
Bayer Schering Pharma AG. He is a member of WHO IMPACT‘s Technology
Subgroup as well as of EFPIA‘s Anti-Counterfeiting ad hoc working
group. |
 |
Prof Dr Ulrike Holzgrabe, University of Würzburg,
Würzburg, Germany
Ulrike Holzgrabe holds a chair in Pharmaceutical Chemistry at the
University of Würzburg and is a member of several national an
international committees dealing with the German and European
Pharmacopoeia. Thus, she is interested in modern analytical methods
for quality assurance of drugs.
|
 |
Prof Dr Klaus-Jürgen Steffens, University of Bonn, Germany
Klaus-J. Steffens holds a chair in Pharmaceutical Technology at the University of Bonn. He is an expert in the development and production of solid dosage forms. The physicochemical characterization of raw materials and final products is one of his most important research fields with more than 20 years experience in special analytical tools, among them spectroscopic methods like NIRS and XRD. /td>
|
 |
Karl Metzger, Welding GmbH & Co. KG, Hamburg,
Germany
Karl Metzger works with Welding GmbH & Co. KG in Hamburg as
Management responsible for the company’s integrated Management
System and is deputy QP for APIs and coordinates Welding’s auditing
activities. He is member of FECC’s’Good Trade and Distribution
Committee’. Furthermore Karl is APIC certified ICH Q7 Auditor and
has more than 10 years experience in global auditing of chemical,
biotechnological and pharmaceutical manufacturers.
|
|
Harald Vogt, Senior Researcher, SAP AG, Karlsruhe,
Germany
Harald Vogt holds a degree in computer science and is technical
project manager for SToP at SAP Research. He has experience in the
areas of security, RFID, and ubiquitous computing. |
 |
Dr Chris Oldenhof, DSM Anti-Infectives, Delft, The
Netherlands
Chris Oldenhof holds a Ph.D. in organic chemistry. He is currently
Manager External Regulatory Affairs at DSM Anti-Infectives, Delft,
The Netherlands. In his 29 years with DSM he has held positions in
R&D, Marketing & Sales and Regulatory Affairs. Within CEFIC (the
European Chemical Industry Council) he is President of APIC (Active
Pharmaceutical Ingredients Committee) and a Board Member of the EFCG
(European Fine Chemicals Group). In addition he is a member of the
Council of Europe’s ad hoc Group on Counterfeit Medicines since
2003.
|
 |
Dr Martin Wesch, Lawyer at Wesch & Buchenroth,
Stuttgart, Germany
Dr Martin Wesch is a lawyer specialising in medical and industrial
law and working for the Stuttgart-based firm of lawyers Wesch &
Buchenroth, which he founded in 2001. Since April 2002, he has been
teaching industrial law at the University of Stuttgart. Since 1994,
Martin Wesch is Managing Director of the Gütegemeinschaft
Pharma-Verpackung e.V., a quality association for pharmaceutical
packaging. |
|
